SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001493152-24-001720
Filing Date
2024-01-08
Accepted
2024-01-08 16:46:18
Documents
3
Period of Report
2024-01-08

Document Format Files

Seq Description Document Type Size
1 formdef14a.htm DEF 14A 1223555
2 formdef14a_001.jpg GRAPHIC 2361
3 formdef14a_002.jpg GRAPHIC 1035
  Complete submission text file 0001493152-24-001720.txt   1229560
Mailing Address 420 LEXINGTON AVE, SUITE 2446 NEW YORK NY 10017
Business Address 420 LEXINGTON AVE, SUITE 2446 NEW YORK NY 10017 (347) 627-0058
TenX Keane Acquisition (Filer) CIK: 0001851484 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-41534 | Film No.: 24520779
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)